Global Preclinical Contract Research Organizations Market to Reach $8 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Preclinical Contract Research Organizations estimated at US$4.9 Billion in the year 2020, is projected to reach a revised size of US$8 Billion by 2027, growing at a CAGR of 7.3% over the analysis period 2020-2027. Toxicology Testing, one of the segments analyzed in the report, is projected to record a 7.7% CAGR and reach US$2.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Bioanalysis & DMPK Studies segment is readjusted to a revised 7.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 6.8% CAGR
The Preclinical Contract Research Organizations market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 6.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.Compound Management Segment to Record 7% CAGR
In the global Compound Management segment, USA, Canada, Japan, China and Europe will drive the 7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$676.9 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.Select Competitors (Total 33 Featured) -
- Envigo Corporation
- Eurofins Scientific
- ICON Plc
- Laboratory Corporation of America, Inc.
- Medpace, Inc.
- MPI research
- PARAXEL International Corporation
- Pharmaceutical Product Development (PPD), LLC
- PRA Health Sciences, Inc.
- Wuxi AppTec
What's New for 2022?
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Frequently Asked Questions about the Global Market for Preclinical Contract Research Organizations
What is the estimated value of the Global Market for Preclinical Contract Research Organizations?
The Global Market for Preclinical Contract Research Organizations was estimated to be valued at $4.9 Billion in 2020.
What is the growth rate of the Global Market for Preclinical Contract Research Organizations?
The growth rate of the Global Market for Preclinical Contract Research Organizations is 7.3%, with an estimated value of $8 Billion by 2027.
What is the forecasted size of the Global Market for Preclinical Contract Research Organizations?
The Global Market for Preclinical Contract Research Organizations is estimated to be worth $8 Billion by 2027.
Who are the key companies in the Global Market for Preclinical Contract Research Organizations?
Key companies in the Global Market for Preclinical Contract Research Organizations include Envigo Corporation, Eurofins Scientific, ICON Plc, Laboratory Corporation of America, Inc., Medpace, Inc., MPI research, PARAXEL International Corporation, Pharmaceutical Product Development (PPD), LLC and Wuxi AppTec.
| Report Attribute | Details |
|---|---|
| No. of Pages | 89 |
| Published | October 2022 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD | $ 4.9 Billion |
| Forecasted Market Value ( USD | $ 8 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Preclinical Contract Research Organizations - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 2: World Historic Review for Preclinical Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 3: World 15-Year Perspective for Preclinical Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
- Table 4: World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 5: World Historic Review for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 6: World 15-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 7: World Recent Past, Current & Future Analysis for Bioanalysis & DMPK Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 8: World Historic Review for Bioanalysis & DMPK Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 9: World 15-Year Perspective for Bioanalysis & DMPK Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 10: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 11: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 12: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 13: World Recent Past, Current & Future Analysis for Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 14: World Historic Review for Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 15: World 15-Year Perspective for Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 16: World Recent Past, Current & Future Analysis for Government & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 17: World Historic Review for Government & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 18: World 15-Year Perspective for Government & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 19: World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 20: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 21: World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 22: World Preclinical Contract Research Organizations Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
- Table 23: World Recent Past, Current & Future Analysis for Compound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 24: World Historic Review for Compound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 25: World 15-Year Perspective for Compound Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 26: World Recent Past, Current & Future Analysis for Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 27: World Historic Review for Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 28: World 15-Year Perspective for Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 29: World Recent Past, Current & Future Analysis for Safety Pharmacology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 30: World Historic Review for Safety Pharmacology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 31: World 15-Year Perspective for Safety Pharmacology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
UNITED STATES
- Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
- Table 32: USA Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 33: USA Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 34: USA 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 35: USA Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 36: USA Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 37: USA 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
CANADA
- Table 38: Canada Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 39: Canada Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 40: Canada 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 41: Canada Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 42: Canada Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 43: Canada 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
JAPAN
- Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
- Table 44: Japan Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 45: Japan Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 46: Japan 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 47: Japan Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 48: Japan Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 49: Japan 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
CHINA
- Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
- Table 50: China Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 51: China Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 52: China 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 53: China Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 54: China Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 55: China 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
EUROPE
- Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
- Table 56: Europe Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- Table 57: Europe Historic Review for Preclinical Contract Research Organizations by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 58: Europe 15-Year Perspective for Preclinical Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
- Table 59: Europe Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 60: Europe Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 61: Europe 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 62: Europe Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 63: Europe Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 64: Europe 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
FRANCE
- Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
- Table 65: France Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 66: France Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 67: France 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 68: France Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 69: France Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 70: France 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
GERMANY
- Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
- Table 71: Germany Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 72: Germany Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 73: Germany 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 74: Germany Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 75: Germany Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 76: Germany 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
ITALY
- Table 77: Italy Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 78: Italy Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 79: Italy 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 80: Italy Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 81: Italy Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 82: Italy 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
UNITED KINGDOM
- Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
- Table 83: UK Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 84: UK Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 85: UK 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 86: UK Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 87: UK Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 88: UK 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
REST OF EUROPE
- Table 89: Rest of Europe Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 90: Rest of Europe Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 91: Rest of Europe 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 92: Rest of Europe Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 93: Rest of Europe Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 94: Rest of Europe 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
ASIA-PACIFIC
- Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
- Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 96: Asia-Pacific Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 97: Asia-Pacific 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 99: Asia-Pacific Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 100: Asia-Pacific 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
REST OF WORLD
- Table 101: Rest of World Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 102: Rest of World Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 103: Rest of World 15-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2012, 2021 & 2027
- Table 104: Rest of World Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- Table 105: Rest of World Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- Table 106: Rest of World 15-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2012, 2021 & 2027
Companies Mentioned
A selection of companies mentioned in this report includes:
- Envigo Corporation
- Eurofins Scientific
- ICON Plc
- Laboratory Corporation of America, Inc.
- Medpace, Inc.
- MPI research
- PARAXEL International Corporation
- Pharmaceutical Product Development (PPD), LLC
- PRA Health Sciences, Inc.
- Wuxi AppTec
